Results 151 to 160 of about 155,199 (206)

Bullous subacute cutaneous lupus erythematosus

Clinical and Experimental Dermatology, 2004
We describe a 59-year-old woman, with a history of autoimmune disease and disseminated uterine leiomyosarcoma, who developed a photoaggravated, blistering skin eruption. An initial rash, at the outset of treatment with chemo- and radiotherapy, resembled erythema multiforme.
Perera, G K, Black, M M, McGibbon, D H
openaire   +3 more sources

Thalidomide in Cutaneous Lupus Erythematosus

American Journal of Clinical Dermatology, 2003
For nearly 50 years, thalidomide has struggled between success and controversy. After causing an epidemic of phocomelia and other birth defects during the 1960s, affecting thousands of neonates, thalidomide was used as a sedative in selective disorders including leprosy.
Michelle T, Pelle, Victoria P, Werth
openaire   +2 more sources

Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus

Arthritis care & research, 2019
Systemic lupus erythematosus (SLE) is a disorder that is heterogeneous and can be difficult to diagnose. One hallmark of the disease is the presence of antinuclear antibodies (ANAs), a feature that has been incorporated into multiple classification ...
M. Tarazi, R. Gaffney, C. Kushner, S. Chakka, V. Werth   +4 more
semanticscholar   +1 more source

Poikilodermatous Subacute Cutaneous Lupus erythematosus

Dermatology, 2003
<i>Background:</i> Subacute cutaneous lupus erythematosus (SCLE) is a distinct subset of lupus erythematosus with unique clinical, immunological and genetic features. Among the unusual variants of SCLE, there is a poikilodermic presentation. However, to date, only 1 case of poikilodermatous SCLE has been reported.
Angelo V, Marzano, Maura, Facchetti, Elvio, Alessi   +2 more
openaire   +2 more sources

Pathogenesis of cutaneous lupus erythematosus

Clinics in Dermatology, 1985
Antibody-dependent mechanisms of tissue damage are the principle mechanism of disease in systemic and cutaneous lupus erythematosus. Antibody-dependent mechanisms of keratinocyte damage appear to be a primary pathogenetic factor in all forms of papulosquamous cutaneous lupus. Photosensitive papulosquamous lupus syndromes, such as subacute cutaneous LE,
D A, Norris, L A, Lee
openaire   +2 more sources

Cutaneous lupus erythematosus induced by drugs - novel insights

Expert Review of Clinical Pharmacology, 2019
Introduction: There is a growing list of drugs implicated in inducing both subacute and chronic forms of cutaneous lupus erythematosus. It is important to recognize these drugs in order to quickly treat patients with drug induced disease.
R. Borucki, V. Werth
semanticscholar   +1 more source

Histopathology of cutaneous lupus erythematosus

Clinics in Dermatology, 1985
The basic histopathologic feature of all cutaneous lesions of lupus erythematosus involves a perivascular mononuclear cell infiltrate with subsequent involvement of the epidermis and appendages. The various histologic alterations affecting the epidermis, dermis, and adnexal structures reflect the particular type of lesion biopsied and the duration of ...
A F, Hood, E R, Farmer
openaire   +2 more sources

Cutaneous lupus erythematosus and its association with systemic lupus erythematosus: A nationwide population‐based cohort study in Korea

Journal of dermatology (Print), 2019
Although lupus erythematosus is known to be more common among women of color, the study populations in previous reports were predominantly Caucasian and there is scarce information on Asian patients.
Y. Baek, Se Ha Park, J. Baek, J. Roh, H. Kim   +4 more
semanticscholar   +1 more source

Cutaneous lupus erythematosus: a review

Dermatologic Clinics, 2002
This article will review and update information about the pathogenesis, clinical presentation, diagnosis, and treatment of cutaneous lupus erythematosus. Lupus erythematosus (LE) can present as a skin eruption, with or without systemic disease. Cutaneous LE is subdivided into chronic cutaneous LE, subacute cutaneous LE and acute LE.
Purvisha, Patel, Victoria, Werth
openaire   +2 more sources

Management of cutaneous lupus erythematosus

Clinics in Dermatology, 1985
Abstract Therapy of cutaneous lupus erythematosus is both an art and a science. The interplay of cosmetic and systemic factors must be understood and managed by the physician, who must, following recognition and diagnosis of the problem, discuss prognosis and life-style modification with the patient. Extensive reassurance usually is necessary.
openaire   +2 more sources